TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs May 30, 1980